Page last updated: 2024-11-04

semustine and Leiomyosarcoma

semustine has been researched along with Leiomyosarcoma in 2 studies

Semustine: 4-Methyl derivative of LOMUSTINE; (CCNU). An antineoplastic agent which functions as an alkylating agent.
semustine : An organochlorine compound that is urea in which the two hydrogens on one of the amino groups are replaced by nitroso and 2-chloroethyl groups and one hydrogen from the other amino group is replaced by a 4-methylcyclohexyl group.

Leiomyosarcoma: A sarcoma containing large spindle cells of smooth muscle. Although it rarely occurs in soft tissue, it is common in the viscera. It is the most common soft tissue sarcoma of the gastrointestinal tract and uterus. The median age of patients is 60 years. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1865)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bedikian, AY1
Valdivieso, M1
Khankhanian, N1
Benjamin, RS1
Bodey, GP1
Chang, P1
Levine, MA1
Wiernik, PH1
Walker, MD1

Trials

1 trial available for semustine and Leiomyosarcoma

ArticleYear
A phase II study of intravenously- administered methyl CCNU in the treatment of advanced sarcomas.
    Cancer, 1976, Volume: 37, Issue:2

    Topics: Clinical Trials as Topic; Drug Evaluation; Giant Cell Tumors; Humans; Infusions, Parenteral; Leiomyo

1976

Other Studies

1 other study available for semustine and Leiomyosarcoma

ArticleYear
Chemotherapy for sarcoma of the stomach.
    Cancer treatment reports, 1979, Volume: 63, Issue:3

    Topics: Adult; Aged; Asparaginase; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, C

1979